BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago LLB Concludes Share Repurchase Programme Successfully Share Repurchase Financial News Vaduz LLB Treasure Shares
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago LLB conclut avec succès son programme de rachat d'actions Rachat D'actions Vaduz Actualités Financières Licence En Droit (LLB) Actions Au Trésor
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago Newron Initiates Phase III ENIGMA-TRS Study for Treatment-Resistant Schizophrenia Newron Pharmaceuticals Evenamide Schizophrenia Treatment Phase III Study TRS Therapy
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago Newron lance l'étude de phase III ENIGMA-TRS pour la schizophrénie résistante au traitement Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie Étude De Phase III Thérapie TRS
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago Valneva's Half-Year 2025 Financial Report: Growth and Strategic Moves Financial Results Strategic Partnerships Revenue Growth Cash Management Regulatory Updates
BRIEF published on 08/12/2025 at 07:05, 8 months 29 days ago Rapport financier semestriel 2025 de Valneva : croissance et évolutions stratégiques Résultats Financiers Partenariats Stratégiques Croissance Des Revenus Gestion De Trésorerie Mises À Jour Réglementaires
BRIEF published on 08/12/2025 at 07:00, 8 months 29 days ago PolyPeptide Group Reports 24% Growth in H1 2025 Revenue Increase Financial Guidance PolyPeptide Group H1 2025 Growth Belgian Site Expansion
BRIEF published on 08/12/2025 at 07:00, 8 months 29 days ago PolyPeptide Group annonce une croissance de 24 % au premier semestre 2025 Augmentation Des Revenus Orientation Financière Groupe De PolyPeptides Croissance Du Premier Semestre 2025 Extension Du Site Belge
Published on 05/09/2026 at 01:30, 1 day 8 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 9 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 14 hours 46 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 13 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 14 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 14 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 14 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 14 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 14 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 14 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 14 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
